These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3560788)

  • 21. Pharmacology, clinical pharmacology and potential therapeutic uses of the specific bradycardiac agent alinidine.
    Harron DW; Shanks RG
    Eur Heart J; 1985 Sep; 6(9):722-9. PubMed ID: 2866961
    [No Abstract]   [Full Text] [Related]  

  • 22. Cardiac electrophysiological effects of falipamil in the conscious dog: comparison with alinidine.
    Boucher M; Chassaing C; Chapuy E
    Eur J Pharmacol; 1996 Jun; 306(1-3):93-8. PubMed ID: 8813620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ST 567 compared with propranolol in stable angina.
    Ceremuzynski L; Nartowicz E; Dluzniewski M; Perkowicz J; Czarnecki W; Burduk P; Budaj A; Bednarz B; Chamiec T; Jurgiel R
    Eur Heart J; 1987 Dec; 8 Suppl L():159-63. PubMed ID: 3330528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alinidine, a new agent which lowers heart rate in patients with angina pectoris.
    Simoons ML; Tummers J; van Meurs-van Woezik H; van Domburg R
    Eur Heart J; 1982 Dec; 3(6):542-5. PubMed ID: 6761122
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-term follow-up of the primary hyperkinetic heart syndrome. An echocardiographic and hemodynamic study.
    Fiorentini C; Olivari MT; Moruzzi P; Guazzi MD
    Am J Med; 1981 Aug; 71(2):221-7. PubMed ID: 7196153
    [No Abstract]   [Full Text] [Related]  

  • 26. Cardiovascular effects of N-allyl clonidine (ST 567, alinidine): a substance with specific bradycardiac action during neuroleptanesthesia in humans.
    Fitzal S; Zimpfer M
    Int J Clin Pharmacol Ther Toxicol; 1982 Sep; 20(9):404-7. PubMed ID: 7141760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemodynamic actions on alinidine during exercise in patients with coronary artery disease.
    Löllgen H; Just H; Wollschläger H; Kersting F
    Z Kardiol; 1981 May; 70(5):425-8. PubMed ID: 7269729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mepindolol sulfate in the hyperkinetic heart syndrome.
    Bonelli J
    Int J Clin Pharmacol Ther Toxicol; 1984 Jan; 22(1):42-4. PubMed ID: 6698659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of obzidan on coronary blood flow in patients with the hyperkinetic type of hemodynamics in the acute period of myocardial infarct].
    Bogatyrev IV; Vakhliaev VD; Makolkin VI; Syrkin AL
    Kardiologiia; 1988 Aug; 28(8):52-5. PubMed ID: 3199656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of alinidine, an N-allyl derivative of clonidine, on regional myocardial perfusion and performance in the pig with or without atrial pacing.
    Verdouw PD; Saxena PR; Schamhardt HC; van der Hoek TM; Rutteman AM
    Eur J Pharmacol; 1980 Jun; 64(4):209-20. PubMed ID: 7389819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hyperkinetic heart syndrome].
    Lohmöller G; Lydtin H
    Fortschr Med; 1971 Aug; 89(22):864-7. PubMed ID: 4403734
    [No Abstract]   [Full Text] [Related]  

  • 32. The effects of propranolol in essential circulatory hyperkinesis.
    Török E; Matos L; Rausch J; Simonyi J
    Int Z Klin Pharmakol Ther Toxikol; 1969 Jul; 2(3):246-52. PubMed ID: 4902019
    [No Abstract]   [Full Text] [Related]  

  • 33. Anion-channel blockade with alinidine: a specific bradycardic drug for coronary heart disease without negative inotropic activity?
    Jaski BE; Serruys PW
    Am J Cardiol; 1985 Aug; 56(4):270-5. PubMed ID: 4025165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of alinidine (St 567) on emotionally induced tachycardia in man.
    Auböck J; Konzett H; Olbrich E
    Eur J Clin Pharmacol; 1982; 21(6):467-71. PubMed ID: 7075652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of drugs on the exercise electrocardiogram.
    Simoons ML; Balakumaran K
    Cardiology; 1981; 68 Suppl 2():124-32. PubMed ID: 7317892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute myocardial infarction receiving thrombolytic therapy.
    Van de Werf F; Janssens L; Brzostek T; Mortelmans L; Wackers FJ; Willems GM; Heidbüchel H; Lesaffre E; Scheys I; Collen D
    J Am Coll Cardiol; 1993 Aug; 22(2):407-16. PubMed ID: 8335810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of alinidine (ST 567) on baroreceptor-heart rate reflexes and its interactions with clonidine on the baroreflex and on the sympathetic terminals of the isolated atrium.
    Heinzow BG; Angus JA; Korner PI
    Eur J Pharmacol; 1982 Oct; 84(3-4):177-87. PubMed ID: 7173318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic and pharmacodynamic properties of alinidine in man.
    Wiegand UW; Kasper W; Meinertz T; Stützle U; Jähnchen E
    J Cardiovasc Pharmacol; 1982; 4(1):59-62. PubMed ID: 6176801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selectivity of alinidine, a bradycardic agent, for SA nodal automaticity versus other cardiac activities in isolated, blood-perfused dog-heart preparations.
    Kawada M; Satoh K; Taira N
    Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):88-102. PubMed ID: 6517649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination of verapamil and beta blockers in systemic hypertension.
    Dargie H; Cleland J; Findlay I; Murray G; McInnes G
    Am J Cardiol; 1986 Feb; 57(7):80D-82D. PubMed ID: 3513518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.